Prime Medicine
PRME
PRME
79 hedge funds and large institutions have $676M invested in Prime Medicine in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
+3
Holders Change %
+3.95%
% of All Funds
1.25%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
16
Increased
36
Reduced
13
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
$48.9M |
2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
$44.9M |
3 |
NAMA
Nikko Asset Management Americas
New York
|
$44.8M |
4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$34.2M |
5 |
BlackRock
New York
|
$42.3M |